Generics Cos. Escape From Darvocet, Darvon MDL

Law360, New York (June 22, 2012, 8:00 PM EDT) -- A Kentucky federal judge tossed the remaining allegations against generic-drug makers on Friday in the multidistrict litigation over injuries tied to Darvocet, Darvon and their generic equivalents, holding that a recent First Circuit ruling could not save claims the drugs were designed defectively.

The ruling serves as a sharp rebuke to the First Circuit's decision to uphold a $26 million award against Mutual Pharmaceutical Co. Inc. in May, one of the most significant victories for a plaintiff suing a generics maker since the U.S. Supreme Court's...
To view the full article, register now.




Case Information

Case Title

In Re: Darvocet, Darvon and Propoxyphene Products Liability Litigation MDL 2226

Case Number



Kentucky Eastern

Nature of Suit

Tort Product Liability


Danny C. Reeves

Date Filed

August 16, 2011

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.